APOTHEEK TAKOFARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK TAKOFARMA
Largest movements
- Cash +€57,894
up €57,894 (+38.9%), from €148,878 to €206,772
mainly Net result for the year (+€77,312) and Depreciation (+€57,165)
- Tangible fixed assets -€45,057
down €45,057 (-8.3%), from €544,254 to €499,197
of which Other tangible fixed assets: -€39,701
- Debts after one year -€27,801
down €27,801 (-11.6%), from €240,602 to €212,801
- Trade debts +€21,267
up €21,267 (+20.1%), from €105,830 to €127,097
- Reserves +€17,312
up €17,312 (+2.6%), from €657,986 to €675,297
- Staff costs +€12,750
up €12,750 (+8.0%), from €159,962 to €172,711
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,160,596 | €1,163,642 | +€3,047 | +0.3% |
| Fixed assets | 21/28 | €546,549 | €500,262 | -€46,287 | -8.5% |
| Intangible fixed assets | 21 | €2,295 | €1,065 | -€1,230 | -53.6% |
| Tangible fixed assets | 22/27 | €544,254 | €499,197 | -€45,057 | -8.3% |
| Land and buildings | 22 | €145,500 | €145,500 | = | 0.0% |
| Plant, machinery and equipment | 23 | €22,575 | €17,219 | -€5,356 | -23.7% |
| Other tangible fixed assets | 26 | €376,179 | €336,479 | -€39,701 | -10.6% |
| Current assets | 29/58 | €614,047 | €663,380 | +€49,333 | +8.0% |
| Stocks and contracts in progress | 3 | €299,112 | €298,741 | -€371 | -0.1% |
| Stocks | 30/36 | €299,112 | €298,741 | -€371 | -0.1% |
| Amounts receivable within one year | 40/41 | €134,474 | €134,648 | +€174 | +0.1% |
| Trade receivables | 40 | €115,558 | €134,053 | +€18,495 | +16.0% |
| Other amounts receivable | 41 | €18,917 | €595 | -€18,322 | -96.9% |
| Cash at bank and in hand | 54/58 | €148,878 | €206,772 | +€57,894 | +38.9% |
| Deferred charges and accrued income | 490/1 | €31,583 | €23,220 | -€8,363 | -26.5% |
| Total equity and liabilities | 10/49 | €1,160,596 | €1,163,642 | +€3,047 | +0.3% |
| Equity | 10/15 | €677,986 | €695,297 | +€17,312 | +2.6% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €657,986 | €675,297 | +€17,312 | +2.6% |
| Distributable reserves | 133 | €657,986 | €675,297 | +€17,312 | +2.6% |
| Amounts payable | 17/49 | €482,610 | €468,345 | -€14,265 | -3.0% |
| Amounts payable after more than one year | 17 | €240,602 | €212,801 | -€27,801 | -11.6% |
| Financial debts | 170/4 | €240,602 | €212,801 | -€27,801 | -11.6% |
| Amounts payable within one year | 42/48 | €238,940 | €253,060 | +€14,120 | +5.9% |
| Current portion of amounts payable after more than one year | 42 | €26,927 | €27,801 | +€874 | +3.2% |
| Trade debts | 44 | €105,830 | €127,097 | +€21,267 | +20.1% |
| Suppliers | 440/4 | €105,830 | €127,097 | +€21,267 | +20.1% |
| Taxes, remuneration and social security | 45 | €35,284 | €38,162 | +€2,878 | +8.2% |
| Taxes | 450/3 | €4,987 | €4,795 | -€192 | -3.9% |
| Remuneration and social security | 454/9 | €30,297 | €33,367 | +€3,070 | +10.1% |
| Other amounts payable | 47/48 | €70,900 | €60,000 | -€10,900 | -15.4% |
| Accrued charges and deferred income | 492/3 | €3,068 | €2,484 | -€583 | -19.0% |
| Remuneration, social security and pensions | 62 | €159,962 | €172,711 | +€12,750 | +8.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €55,404 | €57,165 | +€1,761 | +3.2% |
| Other operating charges | 640/8 | €387 | €998 | +€611 | +158% |
| Non-recurring operating charges | 66A | €2,366 | - | -€2,366 | |
| Gross operating margin | 9900 | €327,333 | €325,995 | -€1,339 | -0.4% |
| Operating profit (loss) | 9901 | €109,214 | €95,120 | -€14,095 | -12.9% |
| Financial income | 75/76B | €2,188 | €1,665 | -€523 | -23.9% |
| Recurring financial income | 75 | €2,188 | €1,665 | -€523 | -23.9% |
| Financial charges | 65/66B | €12,742 | €12,121 | -€621 | -4.9% |
| Recurring financial charges | 65 | €12,742 | €12,121 | -€621 | -4.9% |
| Profit (loss) for the period before taxes | 9903 | €98,660 | €84,663 | -€13,996 | -14.2% |
| Income taxes | 67/77 | €7,983 | €7,352 | -€631 | -7.9% |
| Profit (loss) for the period | 9904 | €90,677 | €77,312 | -€13,365 | -14.7% |
| Profit (loss) for the period to be appropriated | 9905 | €90,677 | €77,312 | -€13,365 | -14.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.